You have 9 free searches left this month | for more free features.

Abatacept

Showing 1 - 25 of 323

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Healthy Participants Trial in Cypress, Miami, Las Vegas (Abatacept)

Not yet recruiting
  • Healthy Participants
  • Abatacept
  • Cypress, California
  • +2 more
Aug 1, 2023

Kidney Transplant Recipient Trial in Atlanta (Abatacept 125Mg/Ml Syringe)

Not yet recruiting
  • Kidney Transplant Recipient
  • Abatacept 125Mg/Ml Syringe
  • Atlanta, Georgia
  • +1 more
Aug 2, 2023

Type 1 Diabetes, Diabetes, Type 1 Trial in Australia (Abatacept (CTLA4-Ig) and nasal insulin (Humulin R®), Abatacept (CTLA4-Ig)

Recruiting
  • Type 1 Diabetes
  • Diabetes Mellitus, Type 1
  • Abatacept (CTLA4-Ig) and nasal insulin (Humulin R®)
  • Abatacept (CTLA4-Ig) and nasal placebo (0.9% sodium chloride)
  • Westmead, New South Wales, Australia
  • +5 more
Feb 15, 2023

Eye Diseases, Uveitis Trial in Leuven (Abatacept 125 MG/ML Prefilled Syringe)

Active, not recruiting
  • Eye Diseases
  • Uveitis
  • Abatacept 125 MG/ML Prefilled Syringe
  • Leuven, Vlaams-Brabant, Belgium
    UZLeuven
Jan 26, 2023

Interstitial Lung Disease, Common Variable Immunodeficiency Trial in Cincinnati (Abatacept, Placebo)

Recruiting
  • Interstitial Lung Disease
  • Common Variable Immunodeficiency
  • Abatacept
  • Placebo
  • Rochester, Minnesota
  • +1 more
Nov 18, 2022

Peanut Allergy Trial in Montréal (Abatacept, Placebo, Peanut oral immunotherapy)

Recruiting
  • Peanut Allergy
  • Abatacept
  • +2 more
  • Montréal, Quebec, Canada
    CHU Sainte-Justine
Dec 6, 2022

Abatacept, Treatment Compliance, Rheumatoid Arthritis Trial in Hangzhou (Janus Kinase Inhibitor, Abatacept)

Recruiting
  • Abatacept
  • +2 more
  • Janus Kinase Inhibitor
  • Abatacept
  • Hangzhou, Zhejiang, China
    Zhejiang Provincial People's Hospital
Jul 5, 2022

Myocarditis Trial (Abatacept 250 MG)

Not yet recruiting
  • Myocarditis
  • Abatacept 250 MG
  • (no location specified)
Jul 5, 2022

Graft Vs Host Disease Trial in New York (Cyclophosphamide, Abatacept, Tacrolimus)

Recruiting
  • Graft Vs Host Disease
  • New York, New York
    NYU Langone Health
Nov 10, 2022

T and B Cell Repertoire Changes in Response to Orencia® in

Recruiting
  • Rheumatoid Arthritis
    • New York, New York
      Hospital for Special Surgery
    Mar 13, 2023

    Rheumatoid Arthritis, Rheumatic Diseases Trial in Leiden (Abatacept, Methotrexate)

    Completed
    • Rheumatoid Arthritis
    • Rheumatic Diseases
    • Leiden, Netherlands
      Leiden University Medical Center
    Aug 16, 2022

    Rheumatoid Arthritis Trial in Lenexa, San Antonio, Salt Lake City (Test Product, Reference product, Reference Medicinal Product)

    Recruiting
    • Rheumatoid Arthritis
    • Test Product
    • +2 more
    • Lenexa, Kansas
    • +2 more
    Nov 8, 2023

    Rheumatoid Arthritis Trial in Lebanon (Abatacept, DMARDs)

    Active, not recruiting
    • Rheumatoid Arthritis
    • Lebanon, New Hampshire
      Dartmouth-Hitchcock Medical Center
    Jul 22, 2022

    Graft-versus-host Disease Trial in New York (Cyclophosphamide, Abatacept, and Tacrolimus for GvHD Prevention)

    Active, not recruiting
    • Graft-versus-host Disease
    • Cyclophosphamide, Abatacept, and Tacrolimus for GvHD Prevention
    • New York, New York
      NYU Langone Health
    Aug 5, 2022

    CTLA4 Haploinsufficency, Chronic Cytopenia Trial run by the National Institute of Allergy and Infectious Diseases (NIAID)

    Recruiting
    • CTLA4 Haploinsufficency
    • Chronic Cytopenia
    • abatacept
    • Placebo
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 24, 2022

    Giant Cell Arteritis Trial in Canada, United States (Abatacept, Placebo)

    Recruiting
    • Giant Cell Arteritis
    • Abatacept
    • Placebo
    • Rochester, Minnesota
    • +5 more
    Jul 11, 2022

    Palindromic Rheumatism, Wrist Trial in Barcelona (Abatacept Injection, hydroxycloroquina)

    Recruiting
    • Palindromic Rheumatism, Wrist
    • Barcelona, Spain
      Hospital Clinic i Provincial de Barcelona
    Mar 24, 2022

    Dermatomyositis Trial in Washington (Abatacept)

    Completed
    • Dermatomyositis
    • Abatacept
    • Washington, District of Columbia
      2300 M Street, 9th floor. Medical Faculty Associates, The George
    Apr 5, 2022

    Abatacept in Participants That Only Recently Started to Develop

    Completed
    • Rheumatoid Arthritis
      • Freiburg im Breisgau, Germany
        Local Institution
      Jun 10, 2022

      Acute Lymphoblastic Leukemia, Myeloblastic Leukemia, Biphenotypic Acute Leukemia Trial (GVHD prevention: post-transplantation

      Not yet recruiting
      • Acute Lymphoblastic Leukemia
      • +5 more
      • GVHD prevention: post-transplantation cyclophosphamide, abatacept, vedolizumab, calcineurin inhibitor
      • (no location specified)
      Aug 23, 2022

      Myocarditis Acute, Cancer Trial in Boston (Abatacept plus, Placebo)

      Recruiting
      • Myocarditis Acute
      • Cancer
      • Abatacept plus
      • Placebo
      • Los Angeles, California
      • +16 more
      Feb 1, 2023

      Safety of Abatacept Treatment in Denmark Using Danish Database

      Active, not recruiting
      • Rheumatoid Arthritis (RA)
      • Psoriatic Arthritis (PsA)
        • Princeton, New Jersey
          Local Institution
        Jun 13, 2022

        GVHD, Malignancy Trial in Canada, United States (Abatacept, )

        Active, not recruiting
        • Graft vs Host Disease
        • Malignancy
        • Abatacept
        • placebo
        • Los Angeles, California
        • +13 more
        Jan 9, 2023

        Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Buffalo, East Hills, West Islip (biological, drug, other)

        Active, not recruiting
        • Recurrent Plasma Cell Myeloma
        • Refractory Plasma Cell Myeloma
        • Abatacept
        • +3 more
        • Buffalo, New York
        • +2 more
        Dec 22, 2022

        Systemic Lupus Erythematosus Trial in Oklahoma City (Abatacept, Placebo)

        Completed
        • Systemic Lupus Erythematosus
        • Abatacept
        • Placebo
        • Oklahoma City, Oklahoma
          Oklahoma Medical Research Foundation
        Jan 19, 2022